Literature DB >> 34981341

Locally Advanced Rectal Cancer: What We Learned in the Last Two Decades and the Future Perspectives.

Vivek Srivastava1, Aakansha Giri Goswami2, Somprakas Basu3, Vijay Kumar Shukla1.   

Abstract

The advancement in surgical techniques, optimization of systemic chemoradiotherapy, and development of refined diagnostic and imaging modalities have brought a phenomenal shift in the treatment of the locally advanced rectal cancer. Although each therapeutic option has shown substantial progress in their field, it is finding their ideal amalgamation which has baffled the clinician and researchers alike. In the effort to identifying the perfect salutary treatment plan, we have even shifted our attention from the trimodal approach to non-operative "watchful waiting" to more recent individualized care. In this article, we acknowledge the scientific progress in the management of locally advanced rectal cancer and compare the opportunities as well as the obstacles while implementing them clinically. We also explore the current challenges and controversies surrounding the multidisciplinary approach and highlight the new trends and recent advances with an ultimate goal to improve the patients' quality of life.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chemoradiotherapy; Neoadjuvant therapy; Non-operative management; Rectal cancer; Surgery; Watchful waiting

Year:  2022        PMID: 34981341     DOI: 10.1007/s12029-021-00794-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  98 in total

1.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

2.  No more 'standard' abdominoperineal excision.

Authors:  John Nicholls
Journal:  Colorectal Dis       Date:  2013-11       Impact factor: 3.788

3.  Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum.

Authors:  A W Cass; R R Million; W W Pfaff
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

4.  Survival after postoperative combination treatment of rectal cancer.

Authors:  H O Douglass; C G Moertel; R J Mayer; P R Thomas; A S Lindblad; A Mittleman; D M Stablein; H W Bruckner
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

5.  Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

6.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.

Authors:  T Holm; A Ljung; T Häggmark; G Jurell; J Lagergren
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

7.  The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results.

Authors:  C A Maurer; P Renzulli; C Kull; S A Käser; L Mazzucchelli; A Ulrich; M W Büchler
Journal:  Ann Surg Oncol       Date:  2011-02-05       Impact factor: 5.344

8.  Improved survival in cancer of the colon and rectum in Sweden.

Authors:  H Birgisson; M Talbäck; U Gunnarsson; L Påhlman; B Glimelius
Journal:  Eur J Surg Oncol       Date:  2005-10       Impact factor: 4.424

9.  The prevention of invasive cancer of the rectum.

Authors:  V A Gilbertsen; J M Nelms
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

10.  Recent advances in the management of carcinoma of the rectum.

Authors:  Somprakas Basu; Vivek Srivastava; Vijay K Shukla
Journal:  Clin Exp Gastroenterol       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.